Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Rinvoq (upadacitinib) and Dupixent (dupilumab) are both medications used to treat inflammatory conditions, such as eczema. However, they belong to different medication classes and have distinct characteristics. Rinvoq is a Janus kinase (JAK) inhibitor taken orally, while Dupixent is a monoclonal antibody given as a subcutaneous (under the skin) injection. Rinvoq is used for a variety of conditions, including rheumatoid arthritis and ulcerative colitis, and is typically taken once daily. In contrast, Dupixent is used for conditions like asthma and eosinophilic esophagitis, with dosing usually every 2 weeks or monthly. Rinvoq is available in both tablet and liquid forms, whereas Dupixent comes as a pre-filled pen or syringe. Common side effects of Rinvoq include a higher risk of infections and acne, while Dupixent may cause injection site reactions and eye inflammation. Additionally, Rinvoq can interact with many medications and should not be taken with grapefruit. Neither medication is available in a generic form.
Rinvoq (upadacitinib)
Dupixent (dupilumab)
Rinvoq (upadacitinib)
Dupixent (dupilumab)
Summary of Rinvoq vs. Dupixent
Summary for JAK inhibitor
Prescription only
Rinvoq (upadacitinib) is a Janus kinase (JAK) inhibitor. It's used to treat certain inflammatory conditions, such as rheumatoid arthritis (RA), ulcerative colitis (UC), and eczema (atopic dermatitis). But it's not a first-choice option and typically only prescribed when other treatments haven't worked well. Rinvoq (upadacitinib) is taken by mouth, usually once daily. It's available as an extended-release tablet (Rinvoq) and an oral solution (Rinvoq LQ), but the two formulations aren't interchangeable. Side effects include a higher risk of infections, acne, and nausea.
Summary for Interleukin antagonist
Prescription only
Dupixent (dupilumab) is an injection that helps treat certain inflammatory conditions. This includes eczema, asthma, and chronic obstructive pulmonary disease (COPD), among others. It's a biologic medication known as an interleukin antagonist that lowers inflammation. Dupixent (dupilumab) comes as prefilled pens and prefilled syringes. It's injected under the skin of the belly or thighs (or in the back of the upper arm with someone's help). The dosing schedule depends on the condition you have, your age, and your weight. It's injected either every week, every 2 weeks, or every 4 weeks. Side effects include injection site reactions and eye problems.
Indications of Rinvoq vs. Dupixent
Indications for
Moderate-to-severe inflammatory conditions in which other treatments haven't worked: